Literature DB >> 3569669

Postchallenge glucose concentration and coronary heart disease in men of Japanese ancestry. Honolulu Heart Program.

R P Donahue, R D Abbott, D M Reed, K Yano.   

Abstract

Since 1965, the Honolulu Heart Program has followed 8006 men of Japanese ancestry, aged 45-70 yr at study entry, for the development of cardiovascular disease. To investigate the role of glucose concentration 1 h after a 50-g challenge on the risk of fatal coronary heart disease (CHD) and nonfatal myocardial infarction (MI), 6394 nondiabetic men were followed for 12 yr for the first development of CHD. The rate of fatal CHD increased linearly with amount of glucose. Men in the fourth quintile of postchallenge glucose (157-189 mg/dl) had twice the age-adjusted risk of fatal CHD of those in the lowest quintile (P less than .05). Relative risk increased to threefold among those in the top quintile and remained statistically significant after adjustment for other risk factors including body mass, total cholesterol, hypertension, left ventricular hypertrophy, and hematocrit (P less than .001). When glucose was considered as a linear term in the proportional hazards model, a highly significant relation was noted with fatal CHD alone and when combined with nonfatal MI (P less than .001). We conclude that a continuously increasing risk gradient exists between postchallenge glucose and subsequent CHD that is independent of other known risk factors.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3569669     DOI: 10.2337/diab.36.6.689

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  45 in total

Review 1.  A cardiologist's view of hypoglycemia.

Authors:  Shailesh Nandish; Jamison Wyatt; Rene Oliveros; Adrienne Stevens Zion; Michael Lujan; Robert Chilton
Journal:  Curr Atheroscler Rep       Date:  2010-03       Impact factor: 5.113

2.  Type 2 diabetes and cardiovascular diseases: do they share a common soil? The Asian Indian experience.

Authors:  Rajendra Pradeepa; Adamsha Nazir; Viswanathan Mohan
Journal:  Heart Asia       Date:  2012-01-01

3.  Impact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the diabetes prevention program.

Authors:  Robert Ratner; Ronald Goldberg; Steven Haffner; Santica Marcovina; Trevor Orchard; Sarah Fowler; Marinella Temprosa
Journal:  Diabetes Care       Date:  2005-04       Impact factor: 19.112

4.  Lower 1,5-anhydroglucitol is associated with adverse clinical events after percutaneous coronary intervention.

Authors:  Takayuki Fujiwara; Masashi Yoshida; Naoyuki Akashi; Hodaka Yamada; Takunori Tsukui; Tomohiro Nakamura; Kenichi Sakakura; Hiroshi Wada; Kenshiro Arao; Takuji Katayama; Tomio Umemoto; Hiroshi Funayama; Yoshitaka Sugawara; Takeshi Mitsuhashi; Masafumi Kakei; Shin-Ichi Momomura; Junya Ako
Journal:  Heart Vessels       Date:  2015-04-29       Impact factor: 2.037

5.  Importance of Postprandial Glucose in Relation to A1C and Cardiovascular Disease.

Authors:  Kenneth S Hershon; Barbara R Hirsch; Ola Odugbesan
Journal:  Clin Diabetes       Date:  2019-07

6.  Is A1C Variability an Independent Predictor for the Progression of Atherosclerosis in Type 2 Diabetic Patients?

Authors:  Chul Sik Kim; So Young Park; Sung Hoon Yu; Jun Goo Kang; Ohk Hyun Ryu; Seong Jin Lee; Eun Gyung Hong; Hyeon Kyu Kim; Doo-Man Kim; Jae Myung Yoo; Sung Hee Ihm; Moon Gi Choi; Hyung Joon Yoo
Journal:  Korean Diabetes J       Date:  2010-06-30

7.  Group of signs: a new method to evaluate glycemic variability.

Authors:  Francesco Zaccardi; Paola Di Stefano; Elena Busetto; Marco Orsini Federici; Andrea Manto; Fabio Infusino; Gaetano Antonio Lanza; Dario Pitocco; Giovanni Ghirlanda
Journal:  J Diabetes Sci Technol       Date:  2008-11

8.  Plasma lipids, lipoproteins, and apolipoproteins in Nigerian diabetes mellitus, essential hypertension, and hypertensive-diabetic patients.

Authors:  O O Oyelola; A A Ajayi; R O Babalola; E A Stein
Journal:  J Natl Med Assoc       Date:  1995-02       Impact factor: 1.798

9.  Administration of tauroursodeoxycholic acid prevents endothelial dysfunction caused by an oral glucose load.

Authors:  Lauren K Walsh; Robert M Restaino; Martha Neuringer; Camila Manrique; Jaume Padilla
Journal:  Clin Sci (Lond)       Date:  2016-08-08       Impact factor: 6.124

10.  Improvement of glucose metabolism in patients with impaired glucose tolerance or diabetes by long-term administration of a palatinose-based liquid formula as a part of breakfast.

Authors:  Masae Sakuma; Hidekazu Arai; Akira Mizuno; Makiko Fukaya; Motoi Matsuura; Hajime Sasaki; Hisami Yamanaka-Okumura; Hironori Yamamoto; Yutaka Taketani; Toshio Doi; Eiji Takeda
Journal:  J Clin Biochem Nutr       Date:  2009-08-28       Impact factor: 3.114

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.